PRESS RELEASE published on 05/05/2026 at 07:30, 1 month 13 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 29ème conférence annuelle de l'ASGCT pour présenter ses thérapies géniques pour la surdité. Détails des présentations et projets en cours Thérapie Génique ASGCT Congrès Sensorion Perte Auditive
PRESS RELEASE published on 05/05/2026 at 07:30, 1 month 13 days ago Inside Information / Other news releases Sensorion announces participation in ASGCT Annual Meeting to present gene therapy treatments for hereditary deafness Gene Therapy Innovative Treatments Sensorion ASGCT Annual Meeting Hereditary Deafness
BRIEF published on 04/21/2026 at 07:35, 1 month 27 days ago Sensorion is preparing for its Annual General Meeting Shareholders General Assembly Preparatory Documents Remote Voting Sensory
BRIEF published on 04/21/2026 at 07:35, 1 month 27 days ago Sensorion prépare son Assemblée Générale annuelle Actionnaires Assemblée Générale Documents Préparatoires Vote À Distance Sensorion
PRESS RELEASE published on 04/21/2026 at 07:30, 1 month 27 days ago Terms of availability of the preparatory documents for the GM Sensorion provides Preliminary Documents for the Combined Shareholders' General Meeting of May 11, 2026. Shareholders urged to participate in a critical meeting addressing new therapies for hearing loss disorders Biotechnology Shareholders' Meeting Gene Therapy Sensorion Hearing Loss
PRESS RELEASE published on 04/21/2026 at 07:30, 1 month 27 days ago Modalités de mise à disposition des documents préparatoires à l'AG Sensorion annonce la mise à disposition des documents préparatoires à l'Assemblée Générale mixte du 11 mai 2026. Les actionnaires peuvent voter à distance. Contact: contact@sensorion-pharma.com Actionnaires Documents Préparatoires Assemblée Générale Mixte Vote À Distance Sensorion
BRIEF published on 03/23/2026 at 07:35, 2 months 26 days ago Mises à jour de Sensorion sur l'essai Audiogene et les progrès du GJB2-GT Essais Cliniques Thérapie Génique Sensorion Perte Auditive SENS-601
BRIEF published on 03/23/2026 at 07:35, 2 months 26 days ago Sensorion Updates on Audiogene Trial and Advances GJB2-GT Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 03/23/2026 at 07:35, 2 months 26 days ago Sensorion poursuit son développement en thérapie génique pour la surdité Thérapie Génique SENS-501 Surdité Congénitale Audiogene SENS-601
BRIEF published on 03/23/2026 at 07:35, 2 months 26 days ago Sensorion continues its development in gene therapy for deafness Gene Therapy Congenital Deafness Audiogene Sense-501 Sense-601
Published on 06/19/2026 at 01:20, 2 hours 38 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 hours 51 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 3 hours 58 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/18/2026 at 23:55, 4 hours 3 minutes ago Relevant Gold Announces Results of Annual and Special General Meeting and Welcomes New Board Member
Published on 06/19/2026 at 03:35, 23 minutes ago From Father's Day to Summer Getaways: How Oxygen Support Helps Protect Health During Europe's Peak Travel Season
Published on 06/19/2026 at 03:00, 58 minutes ago HARDHITTER Showcases Global Leading EV Charging Infrastructure Solutions at Power2Drive Europe 2026
Published on 06/19/2026 at 01:15, 2 hours 43 minutes ago UV Laser Technology Gains Momentum in Europe for Clean, Cold Marking and High-Precision Engraving
Published on 06/18/2026 at 22:35, 5 hours 23 minutes ago Bitmine Immersion Technologies Announces Cash Dividend of $0.1056 per Share of 9.50% Series A Perpetual Preferred Stock
Published on 06/18/2026 at 22:00, 5 hours 58 minutes ago Blue Cap AG: Closing of the Acquisition of Janoschka AG Successfully Completed
Published on 06/18/2026 at 18:00, 9 hours 58 minutes ago Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 mai 2026
Published on 06/18/2026 at 18:00, 9 hours 58 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 10 hours 13 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:45, 10 hours 13 minutes ago EURAZEO INVESTIT DANS LAURALU, ACTEUR PANEUROPÉEN SPÉCIALISTE DES INFRASTRUCTURES INDUSTRIELLES DÉPLOYABLES
Published on 06/18/2026 at 17:45, 10 hours 13 minutes ago ASSEMBLEE GENERALE DU 16 JUIN 2026 : COMPTE-RENDU ET RESULTATS DES VOTES
